(Q28217995)

English

Aspirin resistance in coronary artery disease is correlated to elevated markers for oxidative stress but not to the expression of cyclooxygenase (COX) 1/2, a novel COX-1 polymorphism or the PlA(1/2) polymorphism

scientific article (publication date: May 2006)

In more languages

Statements

scholarly article

0 references

Aspirin resistance in coronary artery disease is correlated to elevated markers for oxidative stress but not to the expression of cyclooxygenase (COX) 1/2, a novel COX-1 polymorphism or the PlA(1/2) polymorphism (English)

0 references

1 reference

based on heuristic

inferred from title

coronary artery disease

1 reference

based on heuristic

inferred from title

author name string

Roger Kranzhofer

1

0 references

Johannes Ruef

2

0 references

language of work or name

0 references

publication date

May 2006

0 references

0 references

17

0 references

3

0 references

163-9

0 references

Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events

1 reference

https://api.crossref.org/works/10.1080/09537100500441101

21 April 2017

Profile and prevalence of aspirin resistance in patients with cardiovascular disease

1 reference

https://api.crossref.org/works/10.1080/09537100500441101

21 April 2017

Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs

1 reference

https://api.crossref.org/works/10.1080/09537100500441101

21 April 2017

Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1080/09537100500441101

21 April 2017

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin

1 reference

https://api.crossref.org/works/10.1080/09537100500441101

21 April 2017

Aspirin resistance and a single gene

1 reference

https://api.crossref.org/works/10.1080/09537100500441101

21 April 2017

Genetic variation in cyclooxygenase 1: effects on response to aspirin

1 reference

https://api.crossref.org/works/10.1080/09537100500441101

21 April 2017

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1080%2F09537100500441101

21 January 2018

Aspirin resistance in cardiovascular disease: a review

1 reference

https://api.crossref.org/works/10.1080%2F09537100500441101

21 January 2018

Aspirin resistance: an evaluation of current evidence and measurement methods

1 reference

https://api.crossref.org/works/10.1080%2F09537100500441101

21 January 2018

A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease

1 reference

https://api.crossref.org/works/10.1080%2F09537100500441101

21 January 2018

Effect of ibuprofen on cardioprotective effect of aspirin

1 reference

https://api.crossref.org/works/10.1080%2F09537100500441101

21 January 2018

In vitro aspirin resistance detected by PFA-100 closure time: pivotal role of plasma von Willebrand factor

1 reference

https://api.crossref.org/works/10.1080%2F09537100500441101

21 January 2018

Flow cytometry analysis of platelet cyclooxygenase-2 expression: induction of platelet cyclooxygenase-2 in patients undergoing coronary artery bypass grafting

1 reference

https://api.crossref.org/works/10.1080%2F09537100500441101

21 January 2018

Effects of different thrombolytic treatment regimen with abciximab and tirofiban on platelet aggregation and platelet-leukocyte interactions: a subgroup analysis from the GUSTO V and FASTER trials

1 reference

https://api.crossref.org/works/10.1080%2F09537100500441101

21 January 2018

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://api.crossref.org/works/10.1080%2F09537100500441101

21 January 2018

Development of aspirin resistance in persons with previous ischemic stroke.

1 reference

https://api.crossref.org/works/10.1080%2F09537100500441101

21 January 2018

Narrative review: aspirin resistance and its clinical implications

1 reference

https://api.crossref.org/works/10.1080%2F09537100500441101

21 January 2018

Selective COX-2 inhibitors and risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1080%2F09537100500441101

21 January 2018

Cyclooxygenase-2 in human platelets as a possible factor in aspirin resistance.

1 reference

https://api.crossref.org/works/10.1080%2F09537100500441101

21 January 2018

Cyclooxygenases 1 and 2

1 reference

https://api.crossref.org/works/10.1080%2F09537100500441101

21 January 2018

Why are some individuals resistant to the cardioprotective effects of aspirin? Could it be thromboxane A2?

1 reference

https://api.crossref.org/works/10.1080%2F09537100500441101

21 January 2018

Isoprostanes: potential markers of oxidant stress in atherothrombotic disease

1 reference

https://api.crossref.org/works/10.1080%2F09537100500441101

21 January 2018

Aspirin insensitive eicosanoid biosynthesis in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1080%2F09537100500441101

21 January 2018

Induction of endothelin-1 expression by oxidative stress in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1080%2F09537100500441101

21 January 2018

Oxidative stress-induced isoprostane formation may contribute to aspirin resistance in platelets

1 reference

https://api.crossref.org/works/10.1080%2F09537100500441101

21 January 2018

Low concentrations of lipid hydroperoxides prime human platelet aggregation specifically via cyclo-oxygenase activation

1 reference

https://api.crossref.org/works/10.1080%2F09537100500441101

21 January 2018

Platelet glycoprotein IIIa polymorphism and coronary thrombosis

1 reference

https://api.crossref.org/works/10.1080%2F09537100500441101

21 January 2018

Pl(A2) polymorphism of beta(3) integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury

1 reference

https://api.crossref.org/works/10.1080%2F09537100500441101

21 January 2018

Common variations in platelet glycoproteins: pharmacogenomic implications

1 reference

https://api.crossref.org/works/10.1080%2F09537100500441101

21 January 2018

Inherited platelet glycoprotein polymorphisms and a risk for coronary heart disease in young central Europeans

1 reference

https://api.crossref.org/works/10.1080%2F09537100500441101

21 January 2018

Platelet PlA2 polymorphism and thromboembolic events: from inherited risk to pharmacogenetics

1 reference

https://api.crossref.org/works/10.1080%2F09537100500441101

21 January 2018

The role of platelet glycoprotein IIIa polymorphism in the high prevalence of in vitro aspirin resistance in patients with intracoronary stent restenosis

1 reference

https://api.crossref.org/works/10.1080%2F09537100500441101

21 January 2018

Glycoprotein IIIA gene (PlA) polymorphism and aspirin resistance: is there any correlation?

1 reference

https://api.crossref.org/works/10.1080%2F09537100500441101

21 January 2018

Aspirin resistance:a new independent predictor of vascular events?**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do no necessarily represent the views of JACCor the American College of

1 reference

https://api.crossref.org/works/10.1080%2F09537100500441101

21 January 2018

Oxidant stress and aspirin-insensitive thromboxane biosynthesis in severe unstable angina

1 reference

https://api.crossref.org/works/10.1080%2F09537100500441101

21 January 2018

Aspirin resistance and genetic polymorphisms

1 reference

https://api.crossref.org/works/10.1080%2F09537100500441101

21 January 2018

Identifiers

10.1080/09537100500441101

0 references

release_vpioiira5zakrlhetrn2d5675y

1 reference

https://api.fatcat.wiki/v0/release/vpioiira5zakrlhetrn2d5675y

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28217995&oldid=1842963363"